SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): APRIL 17, 2002

EXACT SCIENCES CORPORATION
 (Exact Name of Registrant as Specified in Its Charter)

DELAWARE
 (State or Other Jurisdiction of Incorporation)

       000-32179                                         02-0478229
------------------------                     ---------------------------------
(Commission File Number)                     (IRS Employer Identification No.)

63 GREAT ROAD, MAYNARD, MASSACHUSETTS                      01754
----------------------------------------                 ---------
(Address of Principal Executive Offices)                 (Zip Code)	

Registrant's telephone number, including area code: (978) 897-2800

ITEM 5. OTHER EVENTS.
On April 17, 2002, EXACT Sciences Corporation issued a press release, a copy of which is being filed as Exhibit 99.1 to this Current Report on Form 8-K, such press release being incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits
99.1 Press Release dated April 17, 2002.
2

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EXACT Sciences Corporation

April 18, 2002                     By:    /s/ JOHN A. MCCARTHY, JR.
                                          -------------------------------------
                                   Name:  John A. McCarthy, Jr.
                                   Title: Executive Vice President, Chief
                                          Operating Officer, Chief
                                          Financial Officer and Treasurer	

3

                                  EXHIBIT INDEX

EXHIBIT NUMBER    DESCRIPTION

99.1              Press Release dated April 17, 2002.	

4

EXHIBIT 99.1
MAYNARD, MASS. - APRIL 17, 2002 - EXACT Sciences Corporation (NASDAQ: EXAS) announced today it will host a conference call for its first quarter 2002 financial and operating results on Tuesday, April 23, 2002, at 8:30 a.m. EDT. A live Webcast of the conference call can be accessed at www.exactsciences.com through the Investor Relations link. The conference call and the Webcast are open to all interested parties. An archived version of the Webcast will be available at EXACT Sciences' Web site, www.exactsciences.com, through the Investor Relations link, for one month. A replay of the conference call also will be available for 48 hours, following the completion of the live call. EXACT Sciences will announce its first quarter 2002 financial and operating results on Monday, April 22, 2002, after the close of regular market trading hours. Information for the call is as follows:
Information for the call is as follows:
Domestic callers: 800-370-0906
International callers: 973-321-1030
The conference call replay information is as follows:
Domestic callers: 877-519-4471
International callers: 973-341-3080
PIN #: 3233743
ABOUT EXACT SCIENCES CORPORATION
EXACT Sciences Corporation is an applied genomics company that has developed proprietary technologies that may be used for the early detection of several common cancers. EXACT Sciences has selected colorectal cancer as the first application of its technologies. Colorectal cancer is the most deadly cancer among non-smokers, and is curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than 20 years, the rate of early detection of colorectal cancer remains low. EXACT Sciences believes its genomics-based technologies will enable early detection of colorectal cancer so that more people can be effectively treated. Founded in 1995, EXACT Sciences is based in Maynard, Mass. Detailed information on EXACT Sciences can be found on the World Wide Web at www.exactsciences.com.
For further information:
Media:
Amy Turner
Fleishman-Hillard
P: (617) 267-8223
E: turnera@fleishman.com
Investor Relations and Corporate Communications:
Amy Hedison
EXACT Sciences
P: (978) 897-2800, ext. 252
E: ahedison@exactsciences.com